Belton, TX, United States
Belton, TX, United States

Time filter

Source Type

News Article | May 18, 2017
Site: www.PR.com

Platelet-Rich Plasma (PRP) Market Was Valued at US$ 201.2 Million in 2016 SA-BRC is pleased to announce the release of its market research report on the "Global Platelet-Rich Plasma (PRP) Market Assessment & Forecast: 2017-2021." Houston, TX, May 18, 2017 --( The "Global Platelet-Rich Plasma (PRP) Market Assessment & Forecast 2017-2021," report states that global platelet-rich plasma (PRP) market was valued at US$ 201.2 million in 2016 and is forecast to grow to US$ 383.3 million by 2021 at a CAGR of 11.1% from 2017 to 2021. This SA-BRC report covers qualitative and quantitative analysis for major commercial segments segregated by types such as Pure Platelet-Rich Plasma (P-PRP), Leukocyte-Rich Platelet-Rich Plasma (L-PRP), Pure Platelet-Rich Fibrin (P-PRF) and Leukocyte-Rich Platelet-Rich Fibrin (L-PRF). The report also sheds qualitative and quantitative insights into the market of PRP. A section of the report delves into the origin area of the PRP market which is further categorized as autologous platelet-rich plasma, allogeneic platelet-rich plasma and homologous platelet-rich plasma. The PRP market is also analyzed on the basis of application that includes orthopedic surgery, neurosurgery, cosmetic surgery, general surgery and other surgeries. Latter sections of the report focus on the trends and dynamics of the market in terms of competitor analysis. Increasing application areas of PRP and rising geriatric population which are more prone to diseases such as orthopedic diseases, neurological diseases and others drive the growth of the PRP market globally. Increasing incidences of sports injuries, technological advancements, rising number of cosmetic and orthopedic surgeries and growing preference for PRP usage are other factors supporting the growth of the global PRP market. Request Free Report Sample @ http://www.sa-brc.com/Global-Platelet-Rich-Plasma-PRP-Market-Assessment--Forecast-2017-2021/sample36 Significant increase in the number of orthopedic patients propels the need for orthopedic surgeries. According to the estimations of the United Nations University (UNU), the percentage of the world's population above the age of 65 years will increase from 7% in 2000 to 16% in 2050. This increasing in percentage of elderly population would also result in surge of orthopedic patient pool. Thus, the global PRP market is expected to grow remarkably during the study period. North America dominated the global PRP market in 2016, as majority of the key players are domiciled in the region. Also there is high awareness about PRP therapy among the patient population. Manufacturers also are focusing on expanding their geographic presence in the most lucrative market of Asia Pacific. Key players in the global PRP market include Adistem, Ltd., Arteriocyte Medical Systems, Inc., Arthrex, Inc., Zimmer Biomet, CESCA Therapeutics, Dr. PRP America, Regen Lab SA, Harvest Technologies Corporation, Stryker Corporation, DePuy Synthes, EmCyte Corporation, and many more. More Report Description and TOC@ http://www.sa-brc.com/report/Global-Platelet-Rich-Plasma-PRP-Market-Assessment--Forecast-2017-2021/36 Houston, TX, May 18, 2017 --( PR.com )-- SA-BRC announces the release of market assessment report on "Global Platelet-Rich Plasma (PRP) Market Assessment & Forecast 2017 - 2021."The "Global Platelet-Rich Plasma (PRP) Market Assessment & Forecast 2017-2021," report states that global platelet-rich plasma (PRP) market was valued at US$ 201.2 million in 2016 and is forecast to grow to US$ 383.3 million by 2021 at a CAGR of 11.1% from 2017 to 2021.This SA-BRC report covers qualitative and quantitative analysis for major commercial segments segregated by types such as Pure Platelet-Rich Plasma (P-PRP), Leukocyte-Rich Platelet-Rich Plasma (L-PRP), Pure Platelet-Rich Fibrin (P-PRF) and Leukocyte-Rich Platelet-Rich Fibrin (L-PRF). The report also sheds qualitative and quantitative insights into the market of PRP. A section of the report delves into the origin area of the PRP market which is further categorized as autologous platelet-rich plasma, allogeneic platelet-rich plasma and homologous platelet-rich plasma. The PRP market is also analyzed on the basis of application that includes orthopedic surgery, neurosurgery, cosmetic surgery, general surgery and other surgeries. Latter sections of the report focus on the trends and dynamics of the market in terms of competitor analysis. Increasing application areas of PRP and rising geriatric population which are more prone to diseases such as orthopedic diseases, neurological diseases and others drive the growth of the PRP market globally. Increasing incidences of sports injuries, technological advancements, rising number of cosmetic and orthopedic surgeries and growing preference for PRP usage are other factors supporting the growth of the global PRP market.Request Free Report Sample @ http://www.sa-brc.com/Global-Platelet-Rich-Plasma-PRP-Market-Assessment--Forecast-2017-2021/sample36Significant increase in the number of orthopedic patients propels the need for orthopedic surgeries. According to the estimations of the United Nations University (UNU), the percentage of the world's population above the age of 65 years will increase from 7% in 2000 to 16% in 2050. This increasing in percentage of elderly population would also result in surge of orthopedic patient pool. Thus, the global PRP market is expected to grow remarkably during the study period. North America dominated the global PRP market in 2016, as majority of the key players are domiciled in the region. Also there is high awareness about PRP therapy among the patient population. Manufacturers also are focusing on expanding their geographic presence in the most lucrative market of Asia Pacific.Key players in the global PRP market include Adistem, Ltd., Arteriocyte Medical Systems, Inc., Arthrex, Inc., Zimmer Biomet, CESCA Therapeutics, Dr. PRP America, Regen Lab SA, Harvest Technologies Corporation, Stryker Corporation, DePuy Synthes, EmCyte Corporation, and many more.More Report Description and TOC@ http://www.sa-brc.com/report/Global-Platelet-Rich-Plasma-PRP-Market-Assessment--Forecast-2017-2021/36 Click here to view the list of recent Press Releases from SA-BRC


Grant
Agency: Department of Defense | Branch: Air Force | Program: SBIR | Phase: Phase I | Award Amount: 150.00K | Year: 2013

ABSTRACT: The objective of this proposal is to build a foundation for the modeling of polymer powders for use in laser sintering (LS). These models will attempt to provide a basis for characterizing new LS material candidates, establishing a fundamental understanding of material behavior so that existing molding grade polymers can be adapted for use in LS, and qualifying LS feedstock for use in production. BENEFIT: Increased adaptation of LS grade polymers which should lead to decreased raw material costs, increased supply chain security, and broader mechanical properties. In addition, will potentially create a tool to help manage powder feedstock through recycling and mapping process parameters to measured powder quality.


Platelet rich plasma and/or platelet concentrate is prepared by placing whole blood in a first chamber of a sterile processing disposable having two chambers. The processing disposable is subjected to a first centrifugation to separate red blood cells, and the resulting platelet rich plasma supernatant is decanted to the second chamber. The processing disposable is subjected to a second centrifugation to concentrate platelets. A volume of the platelet poor plasma supernatant in the second chamber is removed, and the platelets are re-suspended in the remaining plasma. The second chamber may contain anticoagulant to preclude aggregation of the platelets.


Patent
Harvest Technologies | Date: 2015-06-25

A separator disk for use in centrifugal separation of components is designed to automatically position itself during separation at the interface between the supernatant and the remaining components. Preferably the interface is between plasma and red blood cells.


Patent
Harvest Technologies | Date: 2012-08-16

Adipose is obtained from aspirated adipose by centrifugal separation of adipose from tumescent fluids and oils released from damaged adipose cells. Aspirated adipose is placed in a container having therein a disk that floats on adipose and takes up the released oils whereby they are unlikely to remix with the adipose during handling after centrifugation. The disk also adheres to the adipose by entraining part of the adipose layer.


Patent
Harvest Technologies | Date: 2011-11-23

Devices for extracting bone marrow from a bone of a patient are disclosed. The device includes a housing defined in part by a cannula and a hollow needle disposed within the cannula. The hollow needle is movable axially relative to the cannula and extendable therefrom. The hollow needle is configured to aspirate bone marrow within a bone. A depth adjustment mechanism coupled to the hollow needle and the cannula is used to adjust the depth of the hollow needle relative to the cannula to control the distance of the needle within the bone. The device is attachable to an extraction device to extract bone marrow from the patient through the hollow needle. Methods of using these devices and methods of extracting bone marrow are also included.


Patent
Harvest Technologies | Date: 2011-11-23

Methods and systems for collecting and processing bone marrow in a closed system are provided. The systems and methods include the use of a bone marrow aspiration needle and guide configured to puncture cortical bone. Tube assembly is in fluid flow communication with the bone marrow aspiration needle. A first syringe is in fluid flow communication with the tube assembly and the bone aspiration. A bone marrow aspirate collection container in fluid flow communication with the first syringe and the tube assembly. A second syringe is connected to the collection container, a bone marrow aspirate filter in fluid flow communication with the tube assembly to filter bone marrow aspirate from the first syringe into the collection container. At least one flow controller is configured to direct the flow of bone marrow aspirate between the aspiration needle, the first syringe and the collection container.


Patent
Harvest Technologies | Date: 2016-07-11

A separator disk for use in centrifugal separation of components is designed to automatically position itself during separation at the interface between the supernatant and the remaining components. Preferably the interface is between plasma and red blood cells.


Patent
Harvest Technologies | Date: 2014-01-22

A separator disk for use in centrifugal separation of components is designed to automatically position itself during separation at the interface between the supernatant and the remaining components. Preferably the interface is between plasma and red blood cells.


Patent
Harvest Technologies | Date: 2014-01-21

A floating element for separating components of a physiological fluid comprises two parts that are relatively movable. The two parts define a prescribed volume between them when at their maximum separation, and one of the parts may be moved toward the other to express the fluid contained in the volume between the parts. The parts are made of materials having densities so that they assume a desired position in the fluid to allow selected components to be easily obtained and expressed.

Loading Harvest Technologies collaborators
Loading Harvest Technologies collaborators